The article discusses the challenge of colorectal cancer in the U.S., highlighting the role of the KRAS gene mutation in the disease. Joan Garrett has received a grant to research combination treatments targeting KRAS mutations.

The article describes research on proton re-irradiation for head and neck cancer, presented by Taylor MacDonald, highlighting its role, possible benefits, and associated risks.

Jalen Tucker at the University of Cincinnati underscores the need for continual learning in IT and cybersecurity to keep up with evolving threats. He has gained hands-on experience through co-ops.

Dr. Raj M. Manglik, a renowned University of Cincinnati professor known for his contributions to thermal fluids and energy systems, passed away at 72, leaving a legacy of innovation and mentorship.

Sensory Robotics, at the University of Cincinnati's 1819 Innovation Hub, received a $1.25 million grant for their 3D-sensing safety tech for Air Force hangars.

UC researchers discover a drug targeting a specific protein in pancreatic cancer that may increase survival rates; it has been successful in preclinical trials.

University of Cincinnati researchers, led by Associate Professor LaShan Hendrix, are studying ways to reverse arterial calcification at the cellular level, challenging the belief that it is an inevitable part of aging.

Alique Topalian's research sheds light on the long-term health challenges faced by cancer survivors, emphasizing the need for specialized post-treatment care.

Charity Moeller leads advanced simulation education at the University of Cincinnati's Nursing College, emphasizing practical learning and risk-free collaborative environments.

A University of Cincinnati physicist discusses the roles of dark matter and dark energy, which make up 95% of the universe, in an interview with the BBC.

Butler County prepares for the Autumnal Equinox on September 22, at 2:19 PM EDT, a significant astronomical event with equal day and night lengths.

The University of Cincinnati Cancer Center is advancing the treatment of blood cancers by identifying new mutations and pushing potential treatments through trials, aiming to improve survival rates.

The NSF awarded $3M to UC and Kent State to foster research collaboration with their SHARE program, aiming to aid smaller institutions and streamline processes.